IKZF3 rs9303277: Understanding the 17q12-q21 Asthma Locus
The rs9303277 variant is a common genetic marker located on chromosome 17q12-q21, a region frequently studied for its strong association with asthma susceptibility. Research suggests this variant may influence how the immune system responds to rhinovirus infections, particularly in individuals with specific asthma-related genetic profiles.
What each genotype means
Typical IFN-beta response
This genotype represents the most common sequence at this location. Research indicates that individuals with this profile generally maintain typical interferon-beta (IFN-beta) responses when exposed to rhinovirus, without the specific reduction in response associated with the asthma-risk allele.
Carried by a significant portion of the global population, though exact frequencies vary by ancestry.
Potential reduced immune response
Carrying one copy of the T allele may be associated with a modulation of the immune response to viral triggers. Studies suggest that individuals with asthma who carry this allele may show reduced rhinovirus-induced IFN-beta responses compared to those without it. Please discuss any concerns regarding asthma management or exacerbation triggers with your healthcare provider.
This genotype is common, with the T allele occurring at a frequency of approximately 45% in many populations.
Possible reduced immune response
Carrying two copies of the T allele is associated with the genetic markers linked to reduced rhinovirus-induced IFN-beta responses in some individuals with asthma. This reduced interferon response may influence how your airway cells react to rhinovirus infections. As this is a statistical association observed in research, please consult with your clinician to discuss how this relates to your personal health and respiratory management.
This genotype is common, as the T allele is frequently observed across diverse populations.
What is rs9303277?
The rs9303277 variant is a single nucleotide polymorphism (SNP) located on chromosome 17, specifically within the 17q12-q21 region. This area of the human genome is widely recognized in scientific literature as a major susceptibility locus for asthma, particularly childhood-onset asthma. A SNP represents a variation at a single position in the DNA sequence among individuals. In the case of rs9303277, the variation involves different nucleotides at a specific coordinate. Because this variant sits within a gene-dense region, it is often studied alongside other nearby markers that are in linkage disequilibrium, meaning they are frequently inherited together. Scientists use these markers to better understand the complex genetic architecture that contributes to respiratory health and immune system function.
The Role of the 17q12-q21 Region
The 17q12-q21 locus is home to several genes, including IKZF3, which has been implicated in immune cell development and function. This region is highly complex, and researchers have spent over a decade attempting to identify the specific functional drivers of the observed asthma associations. The genes in this cluster, such as ORMDL3, GSDMB, and ZPBP2, are involved in processes ranging from sphingolipid metabolism to epithelial cell integrity. Because these genes are physically close to one another, it is often difficult for researchers to determine which specific gene or regulatory element is responsible for the clinical associations observed in genome-wide association studies. Ongoing research continues to investigate how variations in this region influence gene expression in lung and immune cells.
Research and Asthma Associations
The evidence linking rs9303277 to asthma is considered moderate to strong, supported by multiple large-scale genome-wide association studies. Recent research has specifically explored the functional impact of this variant on the immune response to rhinovirus, a common trigger for asthma exacerbations. Studies have observed that individuals carrying certain asthma-risk alleles at this locus may exhibit reduced production of interferon-beta (IFN-beta) when exposed to rhinovirus. Interferons are critical signaling proteins that help the body fight viral infections. A reduction in this response could theoretically impact how the airways react to viral triggers. It is important to note that while these statistical associations are significant, they do not imply a direct cause-and-effect relationship for every individual, and the biological mechanisms remain an active area of scientific investigation.
Population Frequency and Diversity
The rs9303277 variant is considered common across various global populations. However, the frequency of the specific alleles can vary significantly depending on ancestral background. For example, some studies have noted that certain alleles at the 17q12-q21 locus are highly prevalent in specific populations, which may contribute to differences in asthma prevalence and severity observed across different ethnic groups. Understanding this diversity is a major focus of current genomics research, as it helps scientists refine risk models and ensure that findings are applicable to diverse groups of people. Because allele frequencies are not uniform, researchers emphasize the importance of studying large, diverse cohorts to fully capture the impact of this variant on human health.
Interpreting Your Genetic Information
If you have access to your genetic data and find that you carry the rs9303277 variant, it is important to view this information in the context of your overall health. Genetic variants are only one piece of a much larger puzzle that includes environmental factors, lifestyle, and other genetic markers. This information is intended for educational purposes and should not be used to diagnose or predict personal health outcomes. If you have concerns about asthma, respiratory health, or how your body responds to infections, please consult with a qualified healthcare professional. They can provide personalized medical advice based on your clinical history and symptoms. Never make changes to your medications or treatment plans based on genetic test results without first discussing them with your doctor or pharmacist.
How common is this variant?
The rs9303277 variant is a common polymorphism found globally, though specific allele frequencies differ significantly across ancestral populations.
Frequently asked questions
Is rs9303277 a diagnostic test for asthma?
No, rs9303277 is not a diagnostic test. Asthma is a complex condition influenced by many genes and environmental factors, and this variant only provides a small piece of statistical information regarding susceptibility.
Does having the T allele mean I will develop asthma?
Not necessarily. Genetic associations describe increased risk at a population level, not individual certainty. Many people with the T allele do not have asthma, and many people with asthma do not carry this specific variant.
Can I change my risk associated with this variant?
You cannot change your DNA. However, managing environmental triggers, maintaining overall respiratory health, and working with a healthcare provider to manage asthma symptoms are effective ways to handle health risks regardless of your genotype.
Where can I find more information on the 17q12-q21 locus?
You can search the GWAS Catalog or PubMed for '17q12-q21 asthma' to find peer-reviewed research. These databases provide access to the latest scientific studies on how this region influences respiratory health.
Sources & further reading
Educational information only, last refreshed 9/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs9303277?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in 17q12-q21
This SNP is linked to altered immune responses to rhinovirus in children with asthma.
This SNP is part of a cluster associated with low IFN-beta induction in response to rhinovirus infection.
This variant is linked to altered interferon responses following rhinovirus infection in asthmatic patients.